| Title |
Naproxen with or without an antiemetic for acute migraine headaches in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2013
|
| DOI | 10.1002/14651858.cd009455.pub2 |
| Pubmed ID | |
| Authors |
Simon Law, Sheena Derry, R Andrew Moore |
| Abstract |
Migraine is a common, disabling condition and a burden for the individual, health services, and society. Many sufferers choose not to, or are unable to, seek professional help and rely on over-the-counter analgesics. Naproxen is a non-steroidal anti-inflammatory drug (NSAID); its efficacy in acute migraine has not been established by systematic reviews. Co-therapy with an antiemetic should help to reduce the nausea and vomiting commonly associated with migraine headaches. |
X Demographics
The data shown below were collected from the profiles of 41 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 8 | 20% |
| Spain | 8 | 20% |
| Ecuador | 2 | 5% |
| Chile | 2 | 5% |
| Germany | 1 | 2% |
| Colombia | 1 | 2% |
| Australia | 1 | 2% |
| Mexico | 1 | 2% |
| United States | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 16 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 78% |
| Practitioners (doctors, other healthcare professionals) | 7 | 17% |
| Scientists | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 250 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | <1% |
| Spain | 1 | <1% |
| Unknown | 247 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 38 | 15% |
| Student > Master | 30 | 12% |
| Researcher | 25 | 10% |
| Student > Ph. D. Student | 17 | 7% |
| Other | 14 | 6% |
| Other | 46 | 18% |
| Unknown | 80 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 77 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 5% |
| Nursing and Health Professions | 12 | 5% |
| Psychology | 11 | 4% |
| Neuroscience | 9 | 4% |
| Other | 38 | 15% |
| Unknown | 90 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 41. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2021.
All research outputs
#1,015,391
of 25,657,205 outputs
Outputs from Cochrane database of systematic reviews
#2,029
of 13,151 outputs
Outputs of similar age
#9,024
of 225,233 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 219 outputs
Altmetric has tracked 25,657,205 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,233 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 219 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.